ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2021
Historique:
received: 30 03 2021
accepted: 07 06 2021
entrez: 5 7 2021
pubmed: 6 7 2021
medline: 21 12 2021
Statut: epublish

Résumé

The insulin-like growth factors (IGF) are important players in the development of gynecological malignancies, including epithelial ovarian cancer (EOC). The identification of biomarkers that can help in the diagnosis and scoring of EOC patients is of fundamental importance in clinical oncology. We have recently identified the

Identifiants

pubmed: 34220714
doi: 10.3389/fendo.2021.688104
pmc: PMC8249937
doi:

Substances chimiques

Cell Cycle Proteins 0
IGF1R protein, human 0
Tumor Suppressor Protein p53 0
ZYG11A protein, human 0
Receptor, IGF Type 1 EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

688104

Informations de copyright

Copyright © 2021 Achlaug, Somri-Gannam, Meisel-Sharon, Sarfstein, Dixit, Yakar, Hallak, Laron, Werner and Bruchim.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Transl Cancer Res. 2016 Dec;5(6):650-663
pubmed: 30613473
Oncotarget. 2016 Feb 16;7(7):8029-42
pubmed: 26771237
Int J Cancer. 2002 Oct 20;101(6):549-54
pubmed: 12237896
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8318-23
pubmed: 8710868
Ann Oncol. 2019 May 1;30(5):672-705
pubmed: 31046081
Am J Pathol. 2004 May;164(5):1511-8
pubmed: 15111296
Endocrinol Metab Clin North Am. 2012 Jun;41(2):231-47, v
pubmed: 22682628
Lancet Oncol. 2012 Dec;13(12):e537-44
pubmed: 23182194
Gynecol Oncol. 2006 Feb;100(2):389-96
pubmed: 16300820
Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):302-10
pubmed: 17315038
Endocr Relat Cancer. 2016 May;23(5):399-410
pubmed: 27090428
Growth Horm IGF Res. 2014 Aug;24(4):112-8
pubmed: 24863809
Front Endocrinol (Lausanne). 2014 May 19;5:76
pubmed: 24904527
Endocrinology. 2004 Oct;145(10):4748-55
pubmed: 15242989
Expert Opin Investig Drugs. 2019 Dec;28(12):1101-1112
pubmed: 31731883
Transl Oncol. 2020 Aug;13(8):100790
pubmed: 32428851
J Cell Physiol. 2013 Apr;228(4):675-9
pubmed: 22926508
Oncotarget. 2019 Jul 08;10(43):4437-4448
pubmed: 31320996
Am J Pathol. 2000 Feb;156(2):409-17
pubmed: 10666369
Proc Natl Acad Sci U S A. 1989 Oct;86(19):7451-5
pubmed: 2477843
Mol Endocrinol. 1991 Nov;5(11):1677-86
pubmed: 1779970
EMBO Rep. 2007 Mar;8(3):279-86
pubmed: 17304241
Semin Oncol. 2007 Apr;34(2 Suppl 2):S1-15
pubmed: 17512352
Hum Pathol. 2011 Jul;42(7):918-31
pubmed: 21683865
Mol Cell Endocrinol. 2021 Feb 15;522:111126
pubmed: 33321115
Mol Hum Reprod. 2001 Dec;7(12):1115-22
pubmed: 11719588
Gynecol Endocrinol. 2008 Mar;24(3):117-21
pubmed: 18335323
J Endocrinol. 1999 Sep;162(3):321-30
pubmed: 10467223
Cell Mol Life Sci. 2014 Jul;71(13):2403-27
pubmed: 24276851
Cells. 2020 Apr 29;9(5):
pubmed: 32365498
Obstet Gynecol Sci. 2020 May;63(3):215-224
pubmed: 32489965
Mol Cell Endocrinol. 2006 Jun 27;252(1-2):241-6
pubmed: 16647191
Expert Opin Ther Targets. 2013 Mar;17(3):307-20
pubmed: 23294364
Clin Cancer Res. 2016 Jun 15;22(12):2897-907
pubmed: 26831715
Surg Obes Relat Dis. 2020 Oct;16(10):1596-1602
pubmed: 32690459
Eur J Endocrinol. 2011 Apr;164(4):485-9
pubmed: 21292919
Lancet. 2004 Apr 24;363(9418):1346-53
pubmed: 15110491
Front Oncol. 2016 Jun 23;6:159
pubmed: 27446805
Genomics. 1995 Mar 1;26(1):151-8
pubmed: 7782076
BMC Med. 2010 Jan 05;8:2
pubmed: 20051101
Lancet. 2009 Oct 17;374(9698):1371-82
pubmed: 19793610
Oncogene. 2012 May 31;31(22):2703-14
pubmed: 21963847
Nat Rev Endocrinol. 2011 Jan;7(1):11-24
pubmed: 20956999
J Cell Biol. 2016 Oct 24;215(2):151-166
pubmed: 27810909
J Mammary Gland Biol Neoplasia. 2008 Dec;13(4):381-406
pubmed: 19016312
Front Endocrinol (Lausanne). 2014 Feb 04;5:10
pubmed: 24550888
N Engl J Med. 2006 Jan 5;354(1):34-43
pubmed: 16394300
Arch Physiol Biochem. 2009 May;115(2):58-71
pubmed: 19485702

Auteurs

Laris Achlaug (L)

Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Lina Somri-Gannam (L)

Gynecology Oncology Laboratory, Department of Obstetrics and Gynecology, Hillel Yaffe Medical Center, Hadera, Israel.
The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

Shilhav Meisel-Sharon (S)

Gynecology Oncology Laboratory, Department of Obstetrics and Gynecology, Hillel Yaffe Medical Center, Hadera, Israel.
The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

Rive Sarfstein (R)

Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Manisha Dixit (M)

David B. Kriser Dental Center, Department of Basic Science and Craniofacial Biology, New York University College of Dentistry, New York, NY, United States.

Shoshana Yakar (S)

David B. Kriser Dental Center, Department of Basic Science and Craniofacial Biology, New York University College of Dentistry, New York, NY, United States.

Mordechai Hallak (M)

Gynecology Oncology Laboratory, Department of Obstetrics and Gynecology, Hillel Yaffe Medical Center, Hadera, Israel.
The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

Zvi Laron (Z)

Endocrine and Diabetes Research Unit, Schneider Children's Medical Center, Petah Tikva, Israel.

Haim Werner (H)

Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ilan Bruchim (I)

Gynecology Oncology Laboratory, Department of Obstetrics and Gynecology, Hillel Yaffe Medical Center, Hadera, Israel.
The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH